WEEKLY PERFORMANCE (09 APR-13 APR 2018)


FUTURE PREMIUM SEGMENT PERFORMANCE FROM CAPITALHEIGHT


OPTION PREMIUM SEGMENT PERFORMANCE FROM CAPITALHEIGHT


CASH PREMIUM SEGMENT PERFORMANCE FROM CAPITALHEIGHT



Weekly Special Report 16th April 2018


NIFTY SNAPSHOT


                 OPEN INTEREST AND VOLUME


TECHNICAL ANALYSIS NIFTY 

        Weekly View of Nifty

Nifty opened the week at 10354, made a high of 10527 and low of 10347 and closed the week at 10490. Thus the Nifty closed the week with a Gain of 136 points. Nifty touched 10,500 and ended marginally higher amid volatility. It started on positive note, in response to the latest macroeconomic data like IIP and CPI inflation which will prove to be favorable for economy. The near-term trend for the Nifty is still positive, and the index which is still sustaining above the hurdle of 10,450-480 levels for this week is likely to have a positive impact for next week. Hence, one may expect upside levels of 10,650 by next week.


The Best Week to Buy Stock – EROS INTL MEDIA

               

             TECHNICAL ANALYSIS STOCK OF EROS INTL MEDIA
















               Weekly View EROS INTL MEDIA


EROS INTL MEDIA is making the lower low pattern on the weekly time frame and is expected to give the breakout next week’s also shows that the stock will move high and will reach the overbought zone. The stock is also getting the support. Buy RSI round 190-210 with the target of 230-250 and stop loss at 170-180. The company revenue was Rs, 144,528 lakhs. The Profit after tax attributable to equity shareholders was Rs, 25,745 lakhs increased by 7.87%.EPS increased by 6.30 % to Rs. 27 as compared to Rs, 25.40 in this quarter. Over the last 2 week, the EROS INTERNATIONAL share price is down 4.0%.now it will take support and will rise up. 

The Best Week to Buy Stock


                                   TECHNICAL ANALYSIS STOCK 

















                            Weekly View Stock

Currently the stock is trading close to 35-week low, which provides investors an opportunity to buy in. The stock is underperforming against the market since oct 2016. It made a high of Rs 895, however, inability to sustain above Gann number of 600-595 led to a strong reversal during the second week of April2018. Auropharma buy round 610-605 with a target of 635-660 with the stop loss at 580. Auro pharma is Q4FY18 turned out to be a good quarter for the pharma division, with retail growth coming.RSI shows that the stock will now take the reversal and will go higher with a good volume. MACD will likely to cross the signal line which suggests the buying.

Weekly Special Report 9th April 2018


                                                 NIFTY SNAPSHOT


            OPEN INTEREST AND VOLUME


                TECHNICAL ANALYSIS NIFTY














                     Weekly View NIFTY

Nifty opened the week at 10198, made a high of 10376 low of 10121 and closed the week at 10352. Thus the Nifty closed the week with a Gain of 154 points.  NIFTY have managed to take resistance at the very important level of 55 EMA, until the low of 10250 on the Nifty is broken.This week, the indices short-term average of 22dma Nifty – 10270 close above it. The indices continue to remain above the medium term average of 55dma Nifty – 10380 but above the long-term average of 200dma Nifty 10130. MACD and Price ROC are both positive and in buy mode. RSI (52) suggests bullish momentum. Thus the trend will remain bullish on the weekly time frame.


The Best Week to Buy Stock - BIOCON


                   TECHNICAL ANALYSIS STOCK OF BIOCON



                            
                           Weekly View BIOCON

BIOCON is forming an uptrend and is forming three method bullish candle pattern gives the buying signal. The moving average indicator is also supporting the buying. . If it breaks above 594 then a steep momentum is expected towards 610 .The RSI is also indicating that the stock is expected to go bullish and is favorable to buy. Buy BIOCON around 592-597  for the target of  610- 625 with stop loss below 575.  Biocon said it expects its partner Mylan to launch insulin glargine across various markets in Europe in the second half of 2018. The company didn't specify the Australian launch but said it will happen later this year.          

The Best Week to Buy Stock - SYNGENE


                  TECHNICAL ANALYSIS STOCK OF SYNGENE



                      Weekly View SYNGENE

SYNGENE International is moving in an uptrend and is making cup and handle pattern on the weekly time frame. It is expected that it can give a breakout which can give the bullish signal. The RSI also shows that the stock is expected to cross over bought level. Buy SYNGENE International around 590 -595 for the target of  620- 630with stop loss below 570 . The stock hit a record high of Rs 670 on 24 January 2018. The stock hit a 52-week low of Rs 430 on 11 August 2017. Syngene International, a leading global contract research services company, announced an research and development (R&D) agreement with GSK, a science-led global healthcare company. After the company said it signed research and development agreement with GSK.